Yeast was the very first non-bacterial organism to have all of its genes sequenced, and the collaborative nature of the EU-funded breakthrough laid the foundations for the sequencing of the human genome less than 10 years later.
Unlocking the DNA of Saccharomyces cerevisiae, a species of yeast used in winemaking, baking and brewing, began through the EU’s Biotechnology Action Plan (BAP) in 1989. Led by Belgian biologist André Goffeau, a total of 147 researchers from 35 laboratories linked forces to sequence chromosome III, one of the 16 chromosomes found in yeast, with the groundbreaking results published in 1992.
‘Without the European funds, I don’t think the project would have happened at all. It certainly wouldn’t have moved as fast as it did,’ said Professor Stephen Oliver, now of Cambridge University, UK, who led the team.
‘Sequencing chromosome III … provided the keys to unlock the genetic potential of yeast.’
Professor Stephen Oliver, Cambridge University, UK
‘Sequencing chromosome III … provided the keys to unlock the genetic potential of yeast and other organisms, because we could define what was there and begin to study the function of genes that, previously, we didn’t even know existed,’ he said.
Mapping the remaining 15 yeast chromosomes was completed with further Framework Programme support for an even wider consortium of researchers in the EU, the US, Japan and Canada, and published in 1996.
Funding from BAP’s successors – the BRIDGE and BIOTECH programmes – helped to identify the functions of specific yeast genes. That was crucial in understanding similar genes in humans, and laid the foundations for sequencing the entire human genome, which was completed in 2003.
Having a blueprint of the inner workings of yeast has been all-important in identifying and developing new strains for making beers and wines with particular flavours or lower alcohol, or to be used in hotter production regions.
New yeast varieties have also helped in efforts to reduce reliance on fossil fuels, through biofuels such as industrial ethanol and biodiesel from plant matter or waste from wood processing.
In medicine, the yeast genome map has allowed yeast to be used to produce new medications and vaccines, and in understanding diseases such as colon cancer and cystic fibrosis. It has also played an important role in developing treatments such as gene therapy.
‘I think the synergy among yeast researchers within Europe was hugely boosted by the chromosome III project and the genome project,’ Prof. Oliver said. ‘The collaborations outlived the sequencing project itself and have continued through other projects.’
To celebrate three decades of the European Commission, Commissioner Carlos Moedas and Director-General Robert-Jan Smits discuss its achievements and current focus, Horizon 2020.
Thousands of metres below the Atlantic Ocean live strange types of coral that no human has ever set eyes on. Or at least that was true until last year, when a group of researchers began investigating the uncharted abyss with a remotely-operated vehicle.
In the summer of 2014 a strange building began to take shape just outside MoMA PS1, a contemporary art centre in New York City. It looked like someone had started building an igloo and then got carried away, so that the ice-white bricks rose into huge towers. It was a captivating sight, but the truly impressive thing about this building was not so much its looks but the fact that it had been grown.
Bilingual people can effortlessly switch between languages during everyday interactions. But beyond its usefulness in communication, being bilingual could affect how the brain works and enhance certain abilities. Studies into this could inform techniques for learning languages and other skills.
Live mycelium networks, capable of information processing, could be used as building materials.
Researchers are investigating whether bilingualism enhances certain cognitive abilities.
Dr Kate Rychert studies ocean plate structures.